Sustained type 2 diabetes management for the elderly Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus
Conditions
Interventions
1. Twenty six patients randomized to intervention group were followed by each of the five multidisplinary diabetes care teams established in the four assigned communities
2. Each team included one pr
Sponsors
Ministry of Health of the People?s Republic of China (China)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Ages 60 and 80 years of age 2. Most recent HbA1c in the prior 6 months was more than or equal to 7.0% 3. Inhabitants in the respective community for more than or equal to 2 years 4. Participants with pubilic medical insurance 5. The proportion ratio is comparable in gender
Exclusion criteria
Exclusion criteria: 1. Patients with cancer 2. Patients with severe cirrhosis 3. Patients with malignant hypertension 4. Patients with severe concurrent illness that would substantially limit life expectancy or require extensive systemic treatment 5. Patients with cognitive, language or hearing impairment severe enough to preclude participation 6. Additionally, patients were also excluded if his or her family member was a physician or nurse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Changes in HbA1c level (target range <7.0%) 2. Changes in low density lipoprotein-cholesterol (LDL-C) concentration (target range <2.6mmol/L) 3. Changes in systolic and diastolic pressure (target range <130/80mmHg) 4. Change in urinary albumin excretion rate (UAER) (target range <30mg/d) 5. The HbA1c level was measured by a high-performance liquid chromatographic assay(Primus), with a normal reference range of 4.0% to 6.0% 6. Blood pressure was measured twice with a mercury sphygmomanometer in the right arm with the patient in a sitting position after a rest of 5 minutes 7. Serum LDL-C and urinary albumin concetration were determined by standard biochemical methods using a chemistry analyzer (Beckman Coulter Synchron clinical system DXC-800) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Measurement of: 1.1. Fasting plasma glucose (FPG) 1.2. Total cholesterol (TC) 1.3. Triglyceride (TG) 1.4. High density lipoprotein-cholesterol (HDL-C) 1.5. Depression screening by the Center for Epidemiologic Studies Depression Scale (CES-D) 2. Plasma glucose, TC, TG and HDL-C were determined by standard biochemical methods using a chemistry analyzer(Beckman Coulter Synchron clinical system DXC-800). 3. Depressive symptoms were evaluated by the CES-D scale which contains 20 items (range 0-60) where a score >16 is considered depressed | — |
Countries
China
Outcome results
None listed